Popular Shingles Vaccine, Zostavax, linked to vision loss and blindness
Adults who are simply looking to protect themselves from getting shingles may be facing unexpected and severe vision complications due to Merck & Co. Inc.’s vaccine, Zostavax. Meyers & Flowers is letting people who have had the vaccine know about this life-altering side effect.
The U.S. Food and Drug Administration approved the popular Zostavax vaccine in 2006. Until recently, it was the only approved shingles vaccine in the U.S. and has been administered more than 36 million times.
In 2016, researchers from the University of Missouri School of Medicine have found a link between the Zostavax vaccine and cases of the corneal inflammation condition called Keratitis. They found those who had received the vaccine and had a history of inflammation of the clear layer on the front of the eye, could see it reactivated by the vaccine. Keratitis can cause serious vision issues and lead to permanent vision damage including blindness in some adults.
The varicella-zoster virus (VZV) causes shingles as well as chickenpox. Scientists believe that when a patient recovers from chickenpox, the virus lays dormant in the body. When it reactivates, it causes shingles. Often, shingles starts with painful itchy or tingling sensation on one side of the face, head or body. A day to five days later a painful rash and blisters will develop in the same areas and can take two to four weeks to heal.
According to the Centers for Disease Control (CDC), almost one out of every three people in the U.S. will develop shingles in their lifetime. There are an estimated one million cases of shingles every year in the U.S. The Zostavax vaccine uses a live strain of the virus to reduce the likelihood of developing shingles by approximately 50 percent.
If you have had vision issues due to the vaccine Zostavax, Meyers & Flowers can help. For more than two decades, our team of attorneys has worked with thousands of patients harmed by dangerous drugs or defective medical devices. Contact us by email, phone or online to explore your legal recourse options.